CSBR

CHAMPIONS ONCOLOGY, INC.

Biological Products, (No Diagnostic Substances)NasdaqNon-accelerated filer<br>Smaller reporting company

Total Trades

18

Buys

18

Sells

0

Largest Trade

$15K–$50K

Insiders

2

Institutional Funds

25

Inst. Value

$1M+

Activist Filings

5

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Mendelson Daniel NewmanDirectorBUY$1K–$15K1K$6.50Jan 16, 2024
Mendelson Daniel NewmanDirectorBUY$1K–$15K500$5.83Jan 4, 2024
Mendelson Daniel NewmanDirectorBUY$1K–$15K3K$4.92Dec 26, 2023
Mendelson Daniel NewmanDirectorBUY$15K–$50K4K$6.16Oct 16, 2023
Mendelson Daniel NewmanDirectorBUY$15K–$50K5K$6.22Oct 16, 2023
Mendelson Daniel NewmanDirectorBUY$1K–$15K2K$5.95Oct 16, 2023
Mendelson Daniel NewmanDirectorBUY$15K–$50K5K$6.40Oct 13, 2023
Mendelson Daniel NewmanDirectorBUY$1K–$15K1K$6.41Oct 11, 2023
Mendelson Daniel NewmanDirectorBUY$1K–$15K2K$6.48Oct 10, 2023
Mendelson Daniel NewmanDirectorBUY$1K–$15K2K$6.47Oct 6, 2023
Mendelson Daniel NewmanDirectorBUY$15K–$50K3K$6.30Oct 4, 2023
Mendelson Daniel NewmanDirectorBUY$15K–$50K5K$6.40Oct 4, 2023
Mendelson Daniel NewmanDirectorBUY$15K–$50K5K$5.65Sep 27, 2023
Mendelson Daniel NewmanDirectorBUY$15K–$50K5K$5.28Sep 25, 2023
Mendelson Daniel NewmanDirectorBUY$15K–$50K4K$5.51Sep 25, 2023
Mendelson Daniel NewmanDirectorBUY$15K–$50K5K$5.51Sep 25, 2023
Mendelson Daniel NewmanDirectorBUY$15K–$50K4K$5.50Sep 25, 2023
Morris RonnieCEOBUY$15K–$50K12K$4.04Mar 21, 2023
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 25 funds holding

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

Tocqueville Asset Management L.P.

SC 13G/A · Feb 14, 2025

4.4%

609K shares

WEST ELK PARTNERS, LP

SC 13G/A · Nov 14, 2024

6.5%

883K shares

New Enterprise Associates 14, L.P.

SC 13D/A · May 6, 2024

12.6%

1.7M shares

Tocqueville Asset Management LP

SC 13G · Feb 13, 2024

5.0%

685K shares

WEST ELK PARTNERS, LP

SC 13G/A · Feb 14, 2022

8.1%

1.1M shares

View on Google Finance →